These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 20628308)

  • 1. Direct economic burden of chronic hepatitis C virus in a United States managed care population.
    Davis KL; Mitra D; Medjedovic J; Beam C; Rustgi V
    J Clin Gastroenterol; 2011 Feb; 45(2):e17-24. PubMed ID: 20628308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population-based hepatitis C surveillance and treatment in a national managed care organization.
    Shatin D; Schech SD; Patel K; McHutchison JG
    Am J Manag Care; 2004 Apr; 10(4):250-6. PubMed ID: 15124501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Burden of illness of hepatitis C from a managed care organization perspective.
    Armstrong EP; Charland SL
    Curr Med Res Opin; 2004 May; 20(5):671-9. PubMed ID: 15140332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic hepatitis C: an age wave of disease burden.
    McHutchison JG; Bacon BR
    Am J Manag Care; 2005 Oct; 11(10 Suppl):S286-95; quiz S307-11. PubMed ID: 16232012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The spectrum of chronic hepatitis C virus infection in the Virginia Correctional System: development of a strategy for the evaluation and treatment of inmates with HCV.
    Sterling RK; Brown RS; Hofmann CM; Luketic VA; Stravitz RT; Sanyal AJ; Contos MJ; Mills AS; Smith V; Shiffman ML
    Am J Gastroenterol; 2005 Feb; 100(2):313-21. PubMed ID: 15667488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Economic burden of rhinitis in managed care: a retrospective claims data analysis.
    Dalal AA; Stanford R; Henry H; Borah B
    Ann Allergy Asthma Immunol; 2008 Jul; 101(1):23-9. PubMed ID: 18681080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The epidemiology of chronic hepatitis C and one-time hepatitis C virus testing of persons born during 1945 to 1965 in the United States.
    Ward JW
    Clin Liver Dis; 2013 Feb; 17(1):1-11. PubMed ID: 23177279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The direct costs of untreated comorbid insomnia in a managed care population with major depressive disorder.
    Asche CV; Joish VN; Camacho F; Drake CL
    Curr Med Res Opin; 2010 Aug; 26(8):1843-53. PubMed ID: 20515321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimating the impact of hepatitis C virus therapy on future liver-related morbidity, mortality and costs related to chronic hepatitis C.
    Buti M; San Miguel R; Brosa M; Cabasés JM; Medina M; Angel Casado M; Fosbrook L; Esteban R
    J Hepatol; 2005 May; 42(5):639-45. PubMed ID: 15826711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The burden of hepatitis C in the United States.
    Kim WR
    Hepatology; 2002 Nov; 36(5 Suppl 1):S30-4. PubMed ID: 12407574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Projecting future complications of chronic hepatitis C in the United States.
    Davis GL; Albright JE; Cook SF; Rosenberg DM
    Liver Transpl; 2003 Apr; 9(4):331-8. PubMed ID: 12682882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Economics of chronic hepatitis B and hepatitis C.
    Rajendra A; Wong JB
    J Hepatol; 2007 Oct; 47(4):608-17. PubMed ID: 17697724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Economic benefits of increased diagnosis of celiac disease in a national managed care population in the United States.
    Green PH; Neugut AI; Naiyer AJ; Edwards ZC; Gabinelle S; Chinburapa V
    J Insur Med; 2008; 40(3-4):218-28. PubMed ID: 19317331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dry eye: prevalence, utilization, and economic implications.
    Dalzell MD
    Manag Care; 2003 Dec; 12(12 Suppl):9-13. PubMed ID: 14723108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of leflunomide versus biologic agents on the costs of care for rheumatoid arthritis in a managed care population.
    Ollendorf DA; Peterson AN; Doyle J; Huse DM
    Am J Manag Care; 2002 May; 8(7 Suppl):S203-13. PubMed ID: 12022236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Doing battle with HCV.
    Fimmel CJ
    Am J Gastroenterol; 2000 Mar; 95(3):582-3. PubMed ID: 10710043
    [No Abstract]   [Full Text] [Related]  

  • 17. Estimates of the direct cost per case and overall burden of trichomoniasis for the employer-sponsored privately insured women population in the United States, 2001 to 2005.
    Owusu-Edusei K; Tejani MN; Gift TL; Kent CK; Tao G
    Sex Transm Dis; 2009 Jun; 36(6):395-9. PubMed ID: 19556934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cost of Alzheimer's disease in managed care: a cross-sectional study.
    Leon J; Neumann PJ
    Am J Manag Care; 1999 Jul; 5(7):867-77. PubMed ID: 10557408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost of atrial fibrillation in United States managed care organizations.
    Kim MH; Lin J; Hussein M; Kreilick C; Battleman D
    Adv Ther; 2009 Sep; 26(9):847-57. PubMed ID: 19768638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimating the future health burden of chronic hepatitis C and human immunodeficiency virus infections in the United States.
    Deuffic-Burban S; Poynard T; Sulkowski MS; Wong JB
    J Viral Hepat; 2007 Feb; 14(2):107-15. PubMed ID: 17244250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.